Neuromyelitis optica in Portugal (NEMIPORT) – A multicentre study
暂无分享,去创建一个
E. Santos | J. Domingos | R. Pedrosa | M. Sá | P. Barros | M. C. Macário | J. Vale | C. Capela | Rita Figueiredo | M. Brum | Luís Isidoro | J. Marques
[1] A. Lutterotti,et al. Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People , 2013, PloS one.
[2] G. Lau,et al. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese , 2013, Journal of Neuroimmunology.
[3] J. Honnorat,et al. Aquaporin-4 antibody–negative neuromyelitis optica , 2013, Neurology.
[4] D. Wingerchuk,et al. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. , 2012, Archives of neurology.
[5] M. Papadopoulos,et al. Aquaporin 4 and neuromyelitis optica , 2012, The Lancet Neurology.
[6] K. Fujihara,et al. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. , 2012, Brain : a journal of neurology.
[7] Jacqueline Palace,et al. Myasthenia gravis and neuromyelitis optica spectrum disorder , 2012, Neurology.
[8] Jacqueline Palace,et al. Serologic diagnosis of NMO , 2012, Neurology.
[9] K. Kyvik,et al. A population-based study of neuromyelitis optica in Caucasians , 2011, Neurology.
[10] J Grimaud,et al. Neuromyelitis optica in France , 2010, Neurology.
[11] D. Centonze,et al. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients , 2009, Multiple sclerosis.
[12] Jeffrey A. Cohen,et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach , 2008, Multiple sclerosis.
[13] A. Vincent,et al. Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. , 2008, International MS journal.
[14] J. Kurtzke,et al. Characteristics of Devic's disease (neuromyelitis optica) in Mexico , 2008, Journal of Neurology.
[15] B. Weinshenker,et al. The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.
[16] B. Weinshenker,et al. Neuromyelitis optica: Changing concepts , 2007, Journal of Neuroimmunology.
[17] M. Sá,et al. Devic disease with abnormal brain magnetic resonance image findings: the first Portuguese case. , 2007, Archives of neurology.
[18] B. Weinshenker,et al. Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.
[19] B. Weinshenker,et al. Brain abnormalities in neuromyelitis optica. , 2006, Archives of neurology.
[20] Ichiro Nakashima,et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.
[21] B. Weinshenker,et al. Neuromyelitis optica , 2003, Neurology.
[22] G. Comi,et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.
[23] J. de Sá. [Epidemiology of multiple sclerosis in Portugal and Spain]. , 2010, Revista de neurologia.
[24] A. Verkman,et al. The Journal of Experimental Medicine CORRESPONDENCE , 2005 .
[25] Massimo Filippi,et al. Clinical characteristics, course and prognosis of relapsing Devic’s Neuromyelitis Optica , 2004, Journal of Neurology.